@Article{Urban2004,
journal="Klinika Oczna / Acta Ophthalmologica Polonica Supplement",
issn="0023-2157",
year="2004",
title="The effectiveness of latanoprost for 
the treatment of pediatric glaucoma",
abstract="Latanoprost is a prostaglandin F2α analog that reduces intraocular pressure by 20-40% in adults with open-angle glaucoma. The efficacy and safety of this drug in children has not been widely reported. In our study we evaluated the effect of latanoprost in 14 children aged 12-18 years (mean 15 years): 10 patients with glaucoma juvenile (I group); 2 patients with secondary glaucoma because of uveitis recidivans and 2 patients with aniridia and albinismus (II group). In the I group the average IOP decrement was 9 mmHg or 36,5% (range 29-44%). In the II group the average IOP decrement was 6,5 mmHg or 23,5% (range 11-33%). In one child with aniridia after one year of treatment IOL rose again to 26 mmHg and antiglaucomatous surgery was necessary. Ocular side effects in children of latanoprost are mild.",
author="Urban, Beata
and Bakunowicz-Łazarczyk, Alina
and Mrugacz, Małgorzata
and Oziębło-Kupczyk, Monika",
pages="243--244",
url="https://www.termedia.pl/The-effectiveness-of-latanoprost-for-r-nthe-treatment-of-pediatric-glaucoma,160,49331,1,1.html"
}